Preston, CT, United States of America

Brett Robinson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Celldex Therapeutics Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brett Robinson. Retrieved from https://idiyas.com/inventor/brett-robinson-r30nk1jg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Brett Robinson

Introduction

Brett Robinson is a notable inventor based in Preston, Connecticut. He has made significant strides in the field of biotechnology, particularly in developing therapeutic solutions for serious health challenges, including cancer. His work exemplifies the impact that dedicated individuals can have on advancing medical science.

Latest Patents

Robinson holds a patent for "Anti-MET antibodies and methods of use thereof." This patent involves compositions and methods that utilize antibodies specifically designed to bind to MET, a receptor tyrosine kinase. These antibodies can modulate the expression or activity of MET, presenting new avenues for managing and treating disorders, especially cancer. The patent details the design of a monoclonal antibody that targets the Sema/PSI domain of human MET, as well as the formulation of a kit that contains this antibody or its antigen-binding fragments.

Career Highlights

Brett Robinson's career has been marked by his association with Celldex Therapeutics Limited, where he plays a crucial role in the development of cutting-edge treatments. His expertise and contributions to the company have been instrumental in advancing therapeutic methods that could have a real-world impact on cancer management.

Collaborations

Throughout his career, Robinson has collaborated with distinguished colleagues, including Yan Yang and Sreekala Mandiyan. These partnerships reflect his commitment to teamwork and innovation, often focusing on the convergence of scientific research and practical applications for treating critical health issues.

Conclusion

In summary, Brett Robinson stands out as an inventive force in the biotechnology sector, with his single but impactful patent laying the groundwork for future advancements in cancer treatment. His collaborations and work at Celldex Therapeutics Limited underscore the importance of innovation in science and medicine, highlighting the vital role inventors play in transforming ideas into tangible benefits for society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…